Relates to requiring insurance coverage for epinephrine auto-injectors

This bill requires New York health insurance plans covering prescription drugs to include coverage for at least two epinephrine auto-injectors for emergency treatment of severe allergic reactions. It caps out-of-pocket costs for these devices at $100 annually, regardless of the plan's deductible, coinsurance, or other cost-sharing rules. The law applies to all major medical, group, and similar health insurance policies sold in New York, including health savings account-qualified plans, with specific provisions to maintain federal eligibility for preventive care coverage. It ensures individuals face a predictable maximum cost for these life-saving devices. The bill was signed into law on February 14, 2025.